New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought
Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.
New Evidence Shows COVID-19 Was in US Weeks Before Thought
New Evidence Shows COVID-19 Was in US Weeks Before Thought

Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

Some of the blood specimens collected in the United States for the NIH’s All of Us research program starting on January 2, 2020, have antibodies against SARS-CoV-2.

precision medicine
Smart Pills Help Monitor Cancer Patients’ Therapy
Smart Pills Help Monitor Cancer Patients’ Therapy
Chia-Yi Hou | Jul 15, 2019
Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.
Contributors
Contributors
The Scientist Staff | Jul 15, 2019
Meet some of the people featured in the July/August 2019 issue of The Scientist.
Opinion: Applying AI to Clinical Care Is Key to Individualized Medicine
Opinion: Applying AI to Clinical Care Is Key to Individualized Medicine
Eric Topol | Jul 15, 2019
Not only can artificial intelligence revolutionize healthcare, it could help restore the doctor-patient relationship.
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Tumor Organoids Hold Promise for Personalizing Cancer Therapy
Jef Akst | Jul 15, 2019
The three-dimensional cell cultures are still in the development phase, but researchers are excited about their use to predict patients’ responses to various treatment options.
Topol on Deep Medicine
Topol on Deep Medicine
The Scientist Staff | Jul 15, 2019
Eric Topol, founder and director of Scripps Research Translational Institute and Reading Frames author, discusses the future of the doctor-patient bond in an era of artificial intelligence–driven medicine.
Orkin on Childhood Cancer
Orkin on Childhood Cancer
The Scientist Staff | Jul 15, 2019
This month’s Profilee, Dana-Farber Cancer Institute researcher Stuart Orkin, talks about treating kids with cancer and other blood disorders.
Startups Plan the Health Data Gold Rush
Startups Plan the Health Data Gold Rush
Shawna Williams | Oct 1, 2018
Companies are building platforms based on blockchain technology to let individuals control and directly profit from their genomic and medical information.
FDA Approves Oral Drug for Fabry Disease
FDA Approves Oral Drug for Fabry Disease
Ashley Yeager | Aug 13, 2018
The medicine increases the activity of a deficient enzyme in certain patients with the condition.
Companies to Help People Sell or Rent Out Their Health Data
Companies to Help People Sell or Rent Out Their Health Data
Catherine Offord | Jun 5, 2018
Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.
NIH Plans to Enroll 1 Million People for Health Database
NIH Plans to Enroll 1 Million People for Health Database
Catherine Offord | May 3, 2018
The agency says it has taken various steps to ensure the privacy of participants’ data. 
New Ovarian Cancer Vaccine Shows Promise
New Ovarian Cancer Vaccine Shows Promise
Catherine Offord | Apr 12, 2018
A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
More than 18,000 Genomic Records from Cancer Patients Available
More than 18,000 Genomic Records from Cancer Patients Available
Kerry Grens | Jun 1, 2017
The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 
Pharma Cooperates to Achieve Precision Medicine
Pharma Cooperates to Achieve Precision Medicine
Catherine Offord | Feb 1, 2017
The challenges of adapting drug development to the age of personalized therapies encourage collaboration among industry players.